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Abstract 
 
 
 
Aging is a universal process that is accompanied by the loss of 
proliferative potential of cells. However, factors governing this age-dependent 
decline in proliferation remain largely undefined. The pancreatic β-cells of the 
islets of Langerhans serve as a unique model to explore the effect of cellular 
age on proliferation and function within the same organ. During early juvenile 
stage, the zebrafish islet is rapidly expanding and newly differentiated β-cells 
are added to the pool of older β-cells that were formed during embryogenesis. 
In this thesis, using accurate reporters for cell-cycle stages and intra-cellular 
calcium sensors, it was shown that younger β-cells are more proliferative but 
less functional compared to older β-cells. Furthermore, as the animal ages, 
the overall rate of β-cell proliferation declines. Transcriptomic analysis of β- 
cells from young adult and older adult islets revealed that older cells display 
an inflammatory signature. Transgenic reporter line for inflammatory NF-kB 
activity showed that β-cells of younger islets display varying levels of NF-kB 
activity, which becomes homogenous in older β-cells. Furthermore, the cells 
with higher NF-kB-activity proliferate less compared to their neighbors with 
lower activity. Specifically, younger NF-kBhigh cells upregulate socs2, a 
negative regulator of proliferation that is also enriched in older β-cells. 
Interestingly, activated macrophages were observed infiltrating the islet during 
late juvenile stages, thus pointing to an important role of the  
microenvironment in activation of inflammatory signature in the islet. Overall, 
this study shows that cells of different ages co-exist within the same micro- 
organ. This age-related cellular heterogeneity governs the rate of proliferation 
of the tissue. The loss of cellular heterogeneity with age reduces the 
proliferative pool of the tissue. Finally, the expression of inflammatory NF-kB 
activity acts as a marker of this loss of proliferative heterogeneity. 
 
 
Abstract 
 
 
 
Das Altern ist ein Prozess, welcher mit dem Verlust des Potenzials zur 
Zellproliferation einhergeht. Faktoren, die diesen altersbedingten Rückgang 
der Proliferation beeinflussen, sind jedoch weitgehend unbekannt. Die β- 
Zellen in den Langerhans-Inseln des Pankreas stellen ein ideales Modell für 
die Erforschung der Auswirkungen des Alterns auf Zellproliferation und - 
funktion dar. Während des frühen juvenilen Stadiums, wachsen die 
Langerhans-Inseln von Zebrafischen sehr schnell. Dabei werden neu 
differenzierte β-Zellen zum Pool von älteren β-Zellen, die während der 
Embryogenese entstanden sind, hinzugefügt. Die vorliegende Arbeit zeigt mit 
Hilfe von Reportern des Zellzyklusstadiums und intrazellulärem Calcium, dass 
jüngere β-Zellen im Vergleich zu älteren, proliferativer aber weniger funktional 
sind. Zudem verringert sich die allgemeine Proliferationsrate mit dem Altern 
des Tieres. Transkriptomanalyse der β-Zellen von jungen erwachsenen und 
älteren Fischen hat deutlich gemacht, dass ältere Zellen eine 
entzündungstypisches Expressionsmuster aufweisen. Durch transgene 
Reporterlinien für inflammatorische NF-kB Aktivität konnte gezeigt werden, 
dass β-Zellen junger Fische verschiedene Level an NF-kB Aktivität aufweisen, 
während die Level in älteren Betazellen homogen sind. Desweiteren 
proliferieren Zellen mit höherer NF-kB Aktivität (NF-kBhigh ) weniger als ihre 
Nachbarzellen mit geringerer Aktivität. Speziell in jüngeren NF-kBhigh Zellen ist 
die Expression von socs2 hochreguliert. Dieser negative Regulator der 
Proliferation liegt auch in älteren β-Zellen angereichert vor. Interessant ist, 
dass aktivierte Makrophagen beobachtet werden konnten, die die 
Langerhans-Inseln während des späten juvenilen Stadiums infiltrierten. Das 
weist auf eine wichtige Rolle der Mikroumgebung in der Aktivierung der 
inflammatorischen Signatur in der Insel hin. 
Zusammenfassend zeigt diese Arbeit, dass Zellen verschiedenen Alters in 
demselben Mikroorgan koexistieren. Diese altersbezogene Heterogenität 
regelt die Proliferationsrate des Gewebes. Der Verlust zellulärer Heterogenität 
im Alter reduziert die Proliferation des Gewebes. Schlussendlich agiert die 
Bildung von inflammatorischem NF-kB als ein Marker dieses Verlustes. 
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1 
Introduction 
 
1.1. Discovery of β-cells and diabetes 
 
A single sentence was found as a record of a disease that had caught 
the attention of physicians as early as 1500 BC; “too great emptying of the 
urine” was found written on an Egyptian papyrus in an ancient grave in 
Thebes. Since then, mentions have been made of patients presenting with 
symptoms of excessive thirst and excessive urination. A symptom that was 
common to all of these patients was the sweet taste of their urine. Around 230 
BC, Apollonius of Memphis used the word “Diabetes” for the first time, 
meaning “to pass through”. It was then thought to be a disease of the kidney, 
and renowned roman physician Galen called it “diarrhea of the kidney”. The 
treatments involved restricting water and food which led to death in most 
cases due to severe dehydration and starvation. Thus, diabetes remained a 
feared disease right up to the discovery of insulin in the 19th century 
(Poretsky, 2010). 
During the nineteenth century, it was observed that patients who died 
of diabetes often presented with a damaged pancreas. In 1869, a German 
medical student, Paul Langerhans, found clusters of cells with unknown 
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function spread throughout the pancreatic tissue that produces digestive 
juices. Some of these cells were eventually shown to be the insulin-producing 
β-cells. Later, in honor of the person who discovered them, the cell clusters 
were named the “islets of Langerhans”. On January 11th, 1922, Frederick 
Banting and Charles Best gave the first insulin injection to a 14-year-old boy 
named Leonard Thompson, from an extract they had prepared for treatment 
of Diabetes in Toronto General Hospital. For the discovery of insulin, 
Frederick Grant Banting and John James Rickard Macleod went on to receive 
the Nobel Prize in Physiology or Medicine in 1923 (Poretsky, 2010). Although 
insulin does not cure diabetes, it is said to be one of the major discoveries in 
medical science. Today diabetes is a well characterized disease. 
Diabetes mellitus can be categorized broadly into two types, type 1 and 
type 2. Type 1 diabetes is an autoimmune disease leading to destruction of β- 
cells and requires lifelong insulin therapy. Potential treatment options for this 
condition include transplantation of isolated islets from cadavers or generation 
of β-cells from stem-cells in vitro, and their subsequent transplantation in 
patients. Type 2 diabetes is the more prevalent form of diabetes. It is 
characterized by hyperglycemia and insulin resistance. In addition to genetic 
predisposition, other factors such as age, pregnancy and obesity have also 
been described as risk factors for diabetes. In fact, women who experience 
hyperglycemia during pregnancy and gestational diabetes have at least a 
seven-fold increased risk of developing type 2 diabetes mellitus at some point 
later in life. (Bellamy et al, 2009). In obese individuals, the adipose tissue 
releases high levels of pro-inflammatory cytokines, free-fatty-acids and other 
factors that are involved in the development of insulin resistance (Kahn et al, 
2006). Furthermore, rare monogenic forms of diabetes resulting from single- 
gene mutations in genes required for β-cell identity and function (e.g. INS, 
KCNJ11, GCK, PDX1) have been identified. Broadly, monogenic diabetes that 
develops in the early stages of life (around 6 months of age) is called neonatal 
diabetes (ND), and diabetes that develops in young adults as maturity-onset 
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diabetes of the young (MODY) (Murphy et al, 2008, Ashcroft & Rorsman, 
2012, Bell & Polonsky, 2001). 
 
 
1.2. β-cell biology and function 
 
The adult endocrine pancreas is a glandular organ composed of 
exocrine and endocrine cells. The exocrine cells include acinar cells, which 
produce digestive enzymes and ductal cells, which carry these digestive 
enzymes into the duodenum. The islets of Langerhans are interspersed 
throughout the pancreas and are composed of hormone-producing endocrine 
cells such as the insulin producing β-cells, glucagon producing α-cells, ghrelin 
producing epsilon-cells, somatostatin producing δ-cells and pancreatic 
polypeptide producing PP-cells. 
The primary function of a β-cell is to sense the circulating blood 
glucose levels and release insulin, which promotes glucose uptake by 
peripheral tissues such as the brain and muscle. Glucose enters the β-cells 
via glucose transporters such as GLUT2, and is rapidly metabolized in the 
cell. The metabolism of glucose increases the intracellular ATP/ADP ratio, 
which blocks the ATP-dependent K+ channels. Blocking of the K+ channels 
depolarizes the cell membrane and causes a rapid influx of Ca2+ in the cell. 
Increase in the intracellular Ca2+ levels promotes secretion of insulin granules 
into the blood stream. The resultant insulin secretion is biphasic in nature,  
with an initial rapid transient peak of insulin release followed by a slowly 
developing second phase of insulin release. In type 2 diabetes, the first-phase 
of insulin secretion is almost abolished, and second-phase of insulin secretion 
is diminished. (Poretsky, 2010, Kulkarni, 2004, and Suckale & Solimena, 
2008). 
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1.3. β-cell development 
 
In mice, the pancreas originates from the foregut endoderm as ventral 
and dorsal buds, as early as at embryonic day e9.5. The dorsal bud forms 
first, followed by the formation of ventral bud, and the two buds fuse at 
approximately e12.5 stage of development. The pancreatic progenitors within 
the foregut epithelium start expressing their marker, pancreatic-duodenal 
homeobox 1 (Pdx1) as early as e8.5. Pdx1 is required for the growth, but not 
the formation, of pancreatic buds. Pdx1−/− mice show normal development of 
both pancreatic buds initially but fail to develop complete pancreatic tissue 
resulting in an apancreatic phenotype at birth. (Spooner et al, 1970). By e13, 
Pdx1 expression is downregulated in acinar and ductal cells but continues to 
be expressed in differentiated endocrine cells throughout life. The second 
wave of endocrine cell differentiation arises at e13.5 and gives rise to more 
endocrine cells that contribute to the mature islets. By e18, shortly before 
birth, most of the endocrine cells have been formed (Ackermann & Gannon, 
2007). 
The zebrafish pancreas consists of the primary islet located at the 
anterior pancreatic head region and is established at the embryonic stage of 
development. The much smaller secondary islets first start to appear around 
5-7 days post fertilization (dpf), and are spread throughout the tail of the 
pancreas. The zebrafish pancreas is formed similar to mice, in that it forms 
from two domains of the endoderm, the dorsal bud (DB) and the ventral bud 
(VB). The dorsal bud emerges by 24 hpf and gives rise to the early endocrine 
cells of the primary islet. The second wave of differentiation comes from the 
ventral bud at around 32 hpf, which gives rise to exocrine cells as well as to a 
few endocrine cells (Tehrani & Lin, 2011, Singh et al, 2017). Furthermore, 
during the early stages of pancreas development, Retinoic acid signaling has 
been shown to be critical in determining pancreatic fate. Animals treated with 
BMS493, a Retinoic Acid Receptor (RAR) antagonist, between 8 and 13 hpf, 
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fail to develop both endocrine and exocrine pancreatic cell types (Stafford & 
Prince, 2002). Similarly, Raldh2−/− mutant mice that lack early RA production 
fail to develop dorsal bud pancreas (Molotkov et al, 2005). In zebrafish, the 
earliest marker of pancreatic differentiation, pdx1 starts appearing at 14 hpf in 
the endodermal cells. Morpholino knockdown of pdx1 in zebrafish leads to a 
loss of endocrine and exocrine cell types, similar to the phenotype seen in 
Pdx1-knockout mice, showing that pdx1 plays a critical role in pancreas 
development (Tehrani & Lin, 2011). Specifically, detailed fate mapping 
experiments and live imaging show that the first β-cells start to appear at 15 
hpf from pdx1 expressing bilateral domains adjacent to the midline. These 
cells are spread out and have not yet coalesced into an islet. Between 18 hpf 
and 48 hpf, β-cells increase in number, converge to form the islet, move 
posteriorly and locate at somites 4-5 by 48 hpf (Kinkel & Prince, 2010). 
One of the most important regulators of endocrine differentiation in 
mice is the transcription factor Ngn3 (Schwitzgebel et al, 2000). Ngn3 is 
essential for endocrine cell differentiation, and Ngn3−/− mice show a lack of all 
pancreatic endocrine cell types and die due to severe diabetes (Gradwohl et 
al, 2000). All the endocrine cells come from Ngn3+ cell lineage. From these 
Ngn3+ cells, lineage tracing experiments have shown that the β- and α-cell 
lineages diverge early, and a switch between Pax4 and Arx expression 
regulates this decision (Collombat et al, 2003). In fact, Arx is upregulated       
in Pax4−/− mice, while Pax4 is upregulated in Arx−/− mice. The α-cells 
differentiate first by upregulating Arx expression, followed by the formation of 
β-cells. Gain-of-function studies have shown that expression of Arx in early 
pancreatic precursor cells (using PdxCre) leads to formation of α-cells at the 
expense of β and δ-cells (Collombat et al, 2007). Much of the developmental 
program is conserved between mice and zebrafish, with the exception of 
Ngn3, which is not expressed in the endocrine progenitors in zebrafish. 
However, they do express NeuroD in endocrine precursor cells, similar to the 
mammalian system (Kinkel & Prince, 2010). 
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The decision of forming the endocrine cells versus exocrine cells is 
made by lateral inhibition within the ductal epithelium via the Notch signaling 
pathway. Cells with active Notch signaling maintain a progenitor state, while 
cells in which Notch signaling is inhibited, express Ngn3, exit the cell cycle, 
and differentiate into endocrine cells (Ackermann & Gannon, 2007). Mice 
deficient for Dll1 (Notch ligand) show accelerated differentiation of pancreatic 
endocrine cells, revealing the notch-responsive cells as precursors of 
endocrine cells (Apelqvist et al, 1999). The complete process of β-cell 
differentiation during embryogenesis, gives rise to the initial β-cell mass of an 
organism. 
In zebrafish, FGF and Notch signaling pathways play an important role 
during early development in deciding endocrine vs. exocrine cell fate. Mutants 
of the fgf10 gene show increased differentiation of endocrine cells at the 
expenses of ducts cells (Dong et al, 2007). Using transgenic reporter lines for 
pax6b and insulin, it was shown that the secondary islets start appearing at 5- 
7 dpf (Parsons et al, 2009). Similar to mice, the ductal cells within the adult 
zebrafish pancreas comprise of Notch-dependent progenitor cells that act as  
a source of endocrine cells. Using drug treatments with Notch inhibitors such 
as DAPT, it was shown that inhibiting Notch signaling causes rapid 
differentiation of endocrine cells (Ninov et al, 2013, Parsons et al, 2009). 
 
 
1.4. β-cell maturation 
 
Although, a majority of β-cell mass has been formed by birth in mice, 
they mature only days after birth as indicated by the ability to produce and 
secrete insulin in response to elevated blood glucose level. Considerable 
effort has been invested in discovering factors that are involved in β-cell 
maturation. Clinically, this is important since generation of mature β-cells in 
vitro, and their subsequent transplantation is considered as an alternative 
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therapy for diabetes. In this regard, several markers of β-cell maturation have 
been identified. Transcriptome analysis of β-cells from prenatal day 1 and 10 
of mice, revealed Urocortin 3 (Ucn3) to be a marker of maturity in mice. 
Recently, ucn3l (urocortin 3-like, a zebrafish orthologue to mammalian Ucn3) 
was shown to associate with glucose-responsive β-cells displaying 
characteristics of β-cell maturity in zebrafish (Singh et al, 2017). In another 
study, weaning of young mice, specifically the transition from high-fat milk to 
high-carbohydrate chow, was shown to be a critical step in β-cell maturation. 
Mice that were prematurely weaned showed a significantly diminished 
glucose-stimulated-insulin-secretion (GSIS) and the β-cells failed to proliferate 
in response to glucose stimulus (Stolovich-rain et al, 2015). Two very 
important markers of β-cell identity and maturation in mammals both in vivo 
and in vitro are MafB and MafA (Hang & Stein, 2011). MafB is expressed in 
immature β-cells during embryogenesis and is required for expression of 
genes such as Pdx1, Glut2 and Nkx6.1. Furthermore, MafB−/− embryos show 
reduced numbers of insulin+ and glucagon+ cells throughout development 
(Artner et al, 2007). While MafB is critical during development, MafA is 
important to maintain β-cell identity and function in adults. Mutant MafA mice 
show reduced GSIS and down-regulation of β-cell identity genes such as Ins, 
Glut2 and Pdx1 (Zhang et al, 2005). Recently, mTOR Complex 1 component, 
RAPTOR, was also shown to be involved in β-cell maturation. Mice with a 
knockout for RAPTOR show impaired GSIS (Ni et al, 2017). 
 
 
1.5. Zebrafish as a model for studying β-cell biology 
 
The zebrafish has been a model organism for developmental biologists 
due to its ease of genetic manipulation, ability to produce multiple off-springs 
and ease of access for imaging during early stages of development. Likewise, 
zebrafish is a model organism for regenerative studies due to its ability to 
regenerate almost every organ, such as the brain, heart, fins, cartilage and 
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the β-cells (Kizil et al, 2012, Lieschke & Currie, 2007, Gemberling et al, 2013, 
Moss et al, 2009). An array of interesting tools to manipulate the β-cells exists 
in the zebrafish. Genetic tools for massive ablation of the β-cells using the 
Metronidazole-Nitroreductase method are very effective leading to almost 
complete ablation of the β-cells (Moss et al, 2009, Moss et al, 2013). It was 
shown that the β-cells are almost completely restored within 3 weeks via 
differentiation from the Notch-responsive centroacinar cells (specialized ductal 
epithelial cells located at the ends of ducts within the acinar lumen) and rapid 
proliferation (Curado et al, 2007, Curado et al, 2008, Delaspre et al, 2015). 
Recent genetic tools have substantially improved the ability to study 
response of β-cells to high glucose using live imaging. A particularly 
interesting tool to study fluctuations in intracellular calcium levels as a proxy 
for β-cell function is GCaMP. GCaMP is a genetically encoded calcium 
indicator (Nakai et al, 2001) consisting of calmodulin fused with GFP with an 
M13 segment. In its native state, the calmodulin-GFP does not emit any 
fluorescence. Upon binding to Ca2+ molecules, GFP undergoes 
conformational change to emit green fluorescence that can be monitored 
using standard confocal microscopes. 
Additionally, elegant tools have been developed to monitor β-cell 
proliferation, such as the fluorescent ubiquitylation-based cell cycle indicator 
(FUCCI) system. The FUCCI system allows monitoring the cell-cycle using 
two fluorescent proteins: mCherry-zCdt1 labels cells in G0/G1 phases of cell- 
cycle with a red fluorescent protein and mAG-zGeminin labels cells in S/G2/M 
phases of cell-cycle with a green fluorescent protein. Furthermore, the FUCCI 
system and other β-cell markers have allowed large-scale drug screens to 
identify small molecules that enhance β-cell proliferation and differentiation 
(Tsuji et al, 2014, Wang et al, 2015). Altogether, these tools make zebrafish 
an important model organism to study β-cell biology. 
Introduction 
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1.6. Factors regulating β-cell proliferation 
 
Each β-cell attempts to precisely sense the level of surrounding 
glucose and release the appropriate amount of insulin in a window of minutes. 
Failing to do so, results in pathologically high levels of blood glucose and 
subsequent complications associated with persistently elevated circulating 
glucose levels. To meet the increased demand for insulin, β-cells must also 
increase in numbers, if required, by undergoing replication. Like most other 
cell types, β-cells proliferate rapidly and increase in number during early 
phases of development in most mammals and enter long-term quiescence 
once the animal is fully developed (Perl et al, 2010, Yun, 2015). However, 
these quiescent β-cells retain the ability to enter proliferation under conditions 
of metabolic stress such as increased demand for insulin during pregnancy 
and obesity (Parsons et al, 1992, Weir et al, 2001). Mature quiescent cells 
may also enter proliferation in order to adapt to the growing demands of tissue 
such as nutrition in case of zebrafish β-cells (Ninov et al, 2013). In addition to 
increased demand, growth factors such as lactogens have also been 
suggested to induce β-cell proliferation (Vasavada et al, 2000). Lactogens 
such as prolactin and placental lactogen have been shown to increase β-cell 
mass in response to increased insulin demand. Transgenic mice 
overexpressing placental lactogen in the β-cells have increased β-cell mass 
and hypoglycemia (Vasavada et al, 2000). 
The switch of rapidly proliferating cells into quiescence during later 
stages of development has been a topic of intense investigation for several 
decades (O'Farrell, 2001). Although many regulators of quiescence including 
low levels of mitogens, nutrient deprivation and contact inhibition have been 
described, it remains a mystery whether the exit from the cell-cycle is a 
stochastic or a tightly regulated process. Previous studies have indicated that 
intrinsic factors, such as chromatin modifications may influence β-cell entry 
into long-term quiescence. For example, transcriptome and methtylome 
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studies have shown that activation of age-dependent methylation markers 
such as H3K27me3 suppresses the expression of pro-proliferation genes in 
both mice and human β-cells (Avrahami et al, 2015, Arda et al, 2016). 
Extrinsic factors, such as the microenvironment of the islet, have also shown 
to play a role in regulating β-cell proliferation and development. It was shown 
that transplanting old islets into the eye chamber of young mice induced 
vascularization of the islets and induced proliferation of the old β-cells 
(Almaça et al, 2014). Recently, it was shown that M2 macrophages induce β- 
cell proliferation by activating SMAD7 expression in β-cells. Blocking 
macrophage infiltration in the islet by pancreatic duct ligation was show to 
block β-cell proliferation, thus showing macrophages as external regulators of 
β-cell proliferation (Xiao et al, 2014). Macrophages have also been implicated 
to play role in normal pancreas development. Mutant Swiss mice lacking 
F4/80-positive macrophages showed reduced β-cell size and impaired 
proliferation during weaning and late pregnancy stages (Banaei-Bouchareb et 
al, 2004). Not only do islet resident macrophages help in development, they 
were also shown to engulf insulin granules using electron microscopy and live 
imaging (Vomund et al, 2015). 
 
 
1.7. β-cell aging and heterogeneity 
 
Do all cells respond equally to the stimuli from their micro-environment, 
or are there inherent differences between cells of an organ that cause sub- 
populations to respond differentially to specific signals? A closer look at a 
single-cell level revealed that β-cells, a seemingly homogenous collection of 
cells, exhibit significant heterogeneity. Recent studies have shown that sub- 
populations of β-cells belonging to “different ages” reside within the same 
islet, with the proportion of young-to-old β-cells being in flux with the age of 
the animal (Meulen et al, 2017, Singh et al, 2017, Aguayo-mazzucato et al, 
2017). In addition, β-cells may vary greatly in their capacity to enter cell-cycle 
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at various stages of life. Several markers of β-cell heterogeneity such as Flat- 
top, ST8SIA1 and CD9 have been identified (Bader et al, 2016, Dorrell et al, 
2016). These markers were shown to identify sub-populations of β-cells with 
differing proliferative and functional properties. However, they have not yet 
been shown to play a direct role in establishing phenotypic differences among 
the β-cell subpopulations. Even though β-cells have been shown to be a 
heterogeneous population, factors that regulate individual cell’s decision to 
enter proliferation remains largely unexplored. This thesis attempts to answer 
the following question: does the relative age of a β-cell affect its decision to 
enter proliferation? 
In order to answer this question, zebrafish β-cells were studied at two 
different stages of development. During the embryonic stages of  
development, the islet is composed of β-cells that arise from two sources of 
endocrine progenitors, the dorsal bud and the ventral bud. By 48 hpf, the 
endocrine cells from the dorsal and ventral buds have fused to form the 
primary islet. The early juvenile stage is a time period of rapid islet expansion. 
During early juvenile stages, the primary islet mass expands by proliferation 
and differentiation of β-cells from post-embryonic progenitor sources which 
then join the islet. Thus, the islet comprises of younger post-embryonic β-cells 
and the relatively older β-cells formed from the dorsal+vental buds. Using live 
imaging of intra-cellular calcium levels and β-cell proliferation reporters, it is 
shown that the younger β-cells are more proliferative while the older β-cells 
are more responsive to surrounding glucose levels within the same islet. 
However, these differences subside at late juvenile stages. Next, 
transcriptomic analysis was performed from β-cells of 3 months post 
fertilization (mpf) and 1 year post fertilization (ypf) animals in order to 
understand molecular regulators of proliferation with age. RNA-Seq and 
single-cell qPCR revealed that genes involved in negative regulation of 
proliferation and inflammation (including components of NF-kB pathway) 
increased with age. Furthermore, the islet of a young 3 mpf animal consists of 
Introduction 
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β-cells showing different levels of inflammatory pathway NF-kB activity. The β- 
cells with higher NF-kB activity are less proliferative as compared to their 
neighbors. Interestingly, activated macrophages were observed to infiltrate  
the islet during late juvenile stages, which pointed to the role of micro- 
environment in the expression of β-cell aging markers. Altogether, the study 
shows that β-cells exhibit decline in proliferative heterogeneity with age and 
identified NF-kB as a marker of this loss of heterogeneity among β-cells. 
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2 
Spatial heterogeneity in a 
developing zebrafish islet 
 
Sections of this chapter have been adapted from the following publication: 
 
Singh SP, Janjuha S, Hartmann T, Kayisoglu Ö, Konantz J, Birke S,  
Murawala P, Alfar EA, Murata K, Eugster A, Tsuji N, Morrissey ER, Brand M & 
Ninov N (2017) Different developmental histories of β-cells generate 
functional and proliferative heterogeneity during islet growth. Nat. Commun. 8: 
664 
 
 
 
2.1. Spatial heterogeneity in β-cell proliferation during 
development of the zebrafish islet 
In the publication by Singh et al, 2017, it was shown that as the islet 
grows with age, endocrine cells from the embryonic source (formed by 48 hpf 
from DB+VB) preferentially locate to the posterior region of the primary islet, 
whereas newly differentiated cells are added to the anterior of the islet. 
Subsequently, this divides the islet into two halves, consisting of the older β- 
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cells in the posterior and the newly differentiated younger cells in the anterior 
region of the primary islet. The period of rapid islet expansion serves as a 
unique time-point to investigate the functional and proliferative differences 
between the older embryonic β-cells and younger post-embryonic β-cells. 
During this phase of development, newly differentiated β-cells from the post- 
embryonic progenitors are constantly being added to the islet’s anterior 
regions, whereas the older, embryonically derived β-cells preferentially 
occupy the islet’s posterior regions. This allows us ask if there are proliferative 
and functional differences among the β-cells of different age within the same 
micro-organ. 
To monitor the endogenous rate of proliferation of zebrafish β-cells, 
previously published β-cell specific fluorescence ubiquitination cell-cycle 
indicator (FUCCI) lines, Tg(ins:Fucci-G1) and Tg(ins:Fucci-S/G2/M) were 
used (Ninov et al, 2013). The FUCCI system uses red fluorescent protein 
fused with CDT1 to label cells in the G0/G1 phases of cell-cycle and green 
fluorescent protein fused with GEMININ to label cells in S/G2/M phases. In 
order to investigate proliferative differences among younger and older β-cells 
within the islet, the percentage of proliferating β-cells were quantified in 
growing islets at 28 dpf, 35 dpf and 45 dpf (Figure 1a & 1b). Quantification 
revealed higher proliferation in the anterior vs. the posterior regions of the 
islets of 28 dpf animals. However, by 35 dpf, the proliferative differences 
between the islet’s anterior and the posterior regions subsided, and the β-cells 
reached homogeneous proliferative levels in the islet. This shows that 
proliferative heterogeneity among β-cells based on the time of differentiation 
declines with age. 
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Figure 1: β-cells differentiating from post-embryonic progenitors are more 
proliferative compared to the embryonic β-cells. 
(a)  Confocal  projections  of   islets   from  Tg(ins:FUCCI-G1);Tg(ins:FUCCI- 
S/G2/M) animals at 28, 35, and 45 dpf. Samples were  collected  ~10 h  after  
feeding. (b) Quantification of  the  percentage  of Tg(ins:FUCCI-S/G2/M)-positive  
and Tg(ins:FUCCI-G1)-negative β-cells in the anterior and  posterior  halves  of  
islets from each stage. At 28 dpf, a higher proportion of proliferating β-cells are 
present in the islet’s anterior half, as compared to the posterior. At 35 and 45 dpf, β-
cell proliferation is similar in both the anterior and the posterior regions.  In  addition, 
β-cell proliferation is reduced compared to 28 dpf (n = 5) (two-tailed t-test, 
*p < 0.05). Scale bars, 20 µm 
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2.2. Spatial heterogeneity in β-cell function during 
development of the zebrafish islet 
Upon glucose stimulation, a surge in intra-cellular calcium levels 
precedes insulin release from the β-cells. The changes in intracellular calcium 
level in response to surrounding glucose concentration thus serves as a proxy 
to study β-cell function. A genetically-encoded calcium indicator 
Tg(ins:GCaMP6s) transgenic line was used to monitor the changes in calcium 
levels in the β-cells (Singh et al., 2017). The Tg(ins:GCaMP6s) line encodes a 
genetically modified calmodulin fused with GFP. In an unbound state, 
GCaMP6s does not emit any fluorescence. Upon binding to Ca2+ molecules, 
GCaMP6s undergoes conformational change to emit green fluorescence that 
can be monitored using standard confocal microscopes. To monitor the 
changes in glucose-stimulated calcium influx specifically in the β-cells, 
GCAMP6s measurements were performed on isolated islets from 
Tg(ins:gCaMP6s;cryaa:mCherry);Tg(ins:Renilla-mKO2;cryaa:CFP) double- 
transgenic animals. The islet is isolated and embedded in 
Fibrinogen/Thrombin gel, which is then mounted on a glass-bottomed dish 
such that the gel polymerizes onto the glass surface (Figure 2a). The gel with 
the embedded islet is immersed in HBSS, and an inverse confocal 
microscope is then used to image the islet over the time-span of glucose 
stimulation. Appropriate volume of 200 mM glucose stock solution is pipetted 
into the HBSS at predefined intervals to generate a glucose ramp. Finally, KCl 
is added to depolarize the cells, thus providing a positive-control signal for 
GCaMP6s expression. For quantifying the calcium oscillations of each β-cell, 
the first 50 frames captured during live-imaging of unstimulated GCaMP6s 
signal (at basal glucose concentrations) is used to normalize the GFP 
intensity observed during the glucose stimulation. 
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Figure 2: The islet’s anterior and posterior cells exhibit temporal differences   
in glucose-responsiveness during post-embryonic development. 
(a) Schematic showing the set-up for mounting the islet for live imaging. The 
isolated islet is embedded in a Fibrinogen/Thrombin gel in a glass bottomed dish  
and imaged using an inverse confocal microscope. The islet is immersed in HBSS 
(see Methods and materials). Appropriate volume of glucose is pipetted in the 
surrounding HBSS solution to reach the desired glucose concentration. 
(b) Quantification showing the posterior/anterior ratio of glucose responsiveness at 
25, 35, and 45 dpf. The differences in glucose responsiveness between the islet’s 
anterior and posterior regions diminish with increasing age. (two tailed t-test, *p  < 
0.05).       (c) Top—ex       vivo        live        imaging        of        islets        from  
25 dpf Tg(ins:GCaMP6s);Tg(ins:mKO2-nls) animals. Β-cells (magenta nuclei) were 
stimulated with a glucose ramp consisting of sequential incubation with 5 (basal),   
10, and 20 mM D-glucose, and depolarized via addition of 30 mM KCl. A  β-cell in  
the islet’s posterior regions (yellow arrowhead) exhibits increasing GCaMP6s- 
fluorescence in response to glucose. The anterior cell (blue arrowhead) only 
responds after KCl addition. More β-cells in the posterior region  respond  to  
glucose, as compared to the anterior. Bottom—trace of normalized GCaMP6s- 
fluorescence intensity over time for each of the two cells indicated  in  the  top  
panels (posterior cell—red trace; anterior cell—blue trace). (c) Top—ex  vivo  
imaging of islets at 45 dpf as in (b). β-cells in the islet’s anterior (blue arrowhead)  
and posterior regions (yellow arrowhead)  exhibit  increasing  GCaMP6s 
fluorescence in response to glucose. Bottom—trace of normalized GCaMP6s 
fluorescence  intensity   for   each   of   the   two   cells   indicated   in   the  top 
panels (posterior cell—red trace; anterior cell—blue trace). Scale bars, 20 µm 
 
 
 
The glucose responsiveness of β-cells in the anterior and posterior 
halves of islet was studied from 25 dpf animals. Islets at 25 dpf were 
stimulated with sequential concentrations of 10 mM and 20 mM glucose and 
monitored in real-time using live-imaging. Remarkably, whereas 67 ± 10% of 
the β-cells in the posterior half of the islet exhibited calcium oscillations upon 
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stimulation only 34 ± 10% of the β-cells in the anterior region responded to the 
same stimulation (n=6) (Figure 2b). 
Notably, the functional differences between the anterior and the 
posterior of the islet equalized at later stages of development at 35 dpf and 45 
dpf. These results suggest that the younger β-cells in the islet’s anterior 
regions, exhibit lower glucose responsiveness compared to the older β-cells in 
the posterior and these functional differences subside with age (Figure 2c & 
2d). The uniform response of β-cells in response to increasing amount of 
glucose continues till adult stages (Figure 3). Overall, the loss of proliferative 
and functional heterogeneity between the anterior and posterior regions 
indicates a reduction in the islet’s heterogeneity with age. 
 
 
Figure 3: Glucose response becomes synchronized in adult islets 
 
(a) Ex vivo live-imaging of β-cells from Tg(ins:nlsRenilla-mKO2);Tg(ins:GCaMP6s) 
animals at 3 mpf. Β-cells (magenta) were stimulated with 2.5 (basal) mM D-Glucose, 
(a’) 11mM D-glucose, (a’’) 16.7 mM D-glucose and (a’’’) depolarized using 30 mM 
KCl while monitoring GCaMP6s-fluorescence (green). Scale bar, 20 µm 
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2.3. Investigating functional differences between 
younger and older β-cells using histone retention 
assay 
To further strengthen the results from the previous observations, 
calcium imaging was combined with histone-retention-assay. In the histone- 
retention-assay, mRNA encoding Histone 2B (H2B) fused with a red 
fluorescent protein, mCherry, was injected in one-cell-staged embryo. The 
underlying principle of the assay is described as follows: with each cell- 
division the levels of H2B-mCherry would dilute by half, thus the newly 
differentiated β-cells would have lower levels of H2B-mCherry due to 
proliferation of the progenitor cells prior to differentiation and the embryonic β- 
cells would retain higher levels of H2B-mCherry. 
Calcium imaging using GCaMP6s was used to compare the glucose- 
responsiveness of the H2B-mCherry-positive and H2B-mCherry-negative β- 
cells at 25 dpf in animals previously injected with the H2B-mCherrry mRNA 
(Figure 4a & 4b). Islets were stimulated with glucose concentrations of 5 to 
7.5 mM. Such low concentrations of glucose used for stimulation would help 
identify cells that are highly glucose responsive. Indeed, 45 ± 12% of the H2B- 
mCherry-positive β-cells showed calcium oscillations, while only 21 ± 6% of 
the H2B-mCherry-negative β-cells responded to glucose stimulation (Figure 
4c). 
Although, the level of H2B-mCherry is not equivalent to lineage tracing 
of embryonic vs. post-embryonic β-cells, nonetheless, this experiment 
strengthened the observation that the older β-cells that retain their H2B- 
mCherry are more functional as compared to the younger β-cells. Altogether, 
it was shown that functional heterogeneity exists in the developing islet and is 
determined by the developmental timing of individual β-cells. 
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Figure 4: Ex vivo live imaging of islets from Tg(ins:GCaMP6s); Tg(ins:CFP- 
NTR) animals at 25 dpf injected with H2B-mCherry mRNA at the one-cell stage. 
(a) β-cells (blue) were stimulated with 5 (basal) and 7.5 mM D-glucose followed by 
depolarization via addition of 30 mM KCl while monitoring GCAMP6s-fluorescence 
(green). A yellow arrow indicates an H2B-mCherry-positive β-cell, whereas the blue 
arrowhead indicates an H2B-mCherry-negative β-cell. (b) Normalized GCaMP6s 
fluorescence intensity trace. The H2B-mCherry-positive cell (red trace, yellow arrow 
in (a)) exhibits oscillating GCaMP6s-fluorescence in response to glucose, while the 
H2B-mCherry-negative cell (blue trace, blue arrowhead in (a)) only responds to 
depolarization with KCl. (c) Quantification showing that a higher proportion of the 
H2B-mCherry-positive β-cells respond to glucose, as compared to the H2B-mCherry- 
negative β-cells. (two-tailed -test, *p < 0.05). Scale bars, 10 µm 
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3 
NF-kB signaling as a marker of 
age-associated heterogeneity 
among β-cells 
 
3.1. β-cell proliferation declines with age in zebrafish 
 
During the late juvenile stages, the proliferative and functional 
heterogeneity observed during earlier stages subsides. This leads to an islet 
with uniform proliferation and glucose responsiveness. In order to study how 
the rate of proliferation changes with overall age of the animal, double 
transgenic Tg(ins:Fucci-G1);Tg(ins:Fucci-S/G2/M) fish were analyzed at 35 
days-post-fertilization (dpf), 3 months-post-fertilization (mpf) and 1 year-post- 
fertilization (ypf) (Figure 5a). As expected, the percentage of Tg(ins:Fucci- 
G1)-negative and Tg(ins:Fucci-S/G2/M)-positive cells among the total number 
of β-cells per islet declined with age. Whereas in islets from 35 dpf animals on 
average 1.53% ± 0.72 (n=5) of the β-cells were proliferating, this number was 
reduced to 0.15% ± 0.07 (n=9) and 0.06% ± 0.02 in islets from 3 mpf and 1 
ypf animals, respectively (n=10) (Figure 5b). 
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Figure 5: βcell proliferation declines with age 
 
(a) Confocal projection of whole-mount islets from Tg(ins:Fucci-G1);Tg(ins:Fucci- 
S/G2/M) animals at 35 dpf, 3 mpf and 1 ypf. Anterior to the top. Scale bar 50 µm. 
(b) Quantification of percentage of Tg(ins:Fucci-S/G2/M)-positive and Tg(ins:Fucci- 
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G1)-negative (green-only) β-cells at 35 dpf (n=5), 3 mpf (n=9) and 1 ypf (n=10) 
animals. Each dot represents one animal. Horizontal bars represent mean values 
(one-way ANOVA, * p<0.05). (c) Schematic showing ablation model using 
Metronidazole-Nitroreductase method. Nitroreductaase is expressed in the β-cells 
under the control of insulin promoter and tagged with YFP protein for visualization. 
Cells expressing Nitroreductase are specifically abalated upon treatment with 
Metronidazole. (d) Confocal projection of sectioned islets from 3 mpf Tg(ins:YFP- 
NTR3)animals. Left – Control, unablated islet and right – 6 days post ablation (dpa) 
islet. Islets were stained with anti-bodies against insulin (magenta) and PCNA 
(green). (e) Quantification of percentage of PCNA+ insulin+ cells at 6 dpa in 3mpf 
animals. Each dot represents one animal. Horizontal bars represent mean values (t- 
test, *p<0.05). 
 
 
 
 
 
In order to confirm if the loss of β-cell proliferation with increasing age 
is not from the inability of β-cells to proliferate after 3 mpf of age, β-cells were 
ablated by Metronidazole-Nitroreductase system using Tg(ins:YFP-NTR3) line 
(Figure 5c). This transgenic line expresses Nitroreductase enzyme from E.coli 
specifically in the β-cells, fused to YFP with T2A in order to visualize the β- 
cells. Upon treating the animals with the antibiotic Metronidazole, the β-cells 
undergo rapid cell death. The islets were observed at 6 days-post-ablation (6 
dpa), and using BrdU incorporation assay it was observed that up to 2% of β- 
cells were proliferating (Figure 4d & 4e). This suggested that the decline in the 
rate of proliferation with increasing age may not come from permanent loss of 
ability to proliferate. 
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3.2. Age-associated molecular heterogeneity among 
the β-cells 
To identify the molecular players involved in the decline of β-cell 
proliferation with age, fluorescence-activated cell sorting (FACS) coupled with 
next generation RNA-Sequencing was used to determine changes in gene 
expression in β-cells with age. Islets were isolated from 3 mpf and 1 ypf 
animals to profile the β-cells (Figure 6a). These two stages were chosen in 
order to avoid additional transcriptional variability in gene expression 
associated with the morphogenesis and the remodeling of the islets during the 
juvenile stages (Singh et al, 2017). The transcriptomes of β-cells at 3 mpf and 
1 ypf revealed 74 genes that showed 1.5-log2fold difference (p <0.05) in 
expression, of which 61 genes were upregulated and 13 genes were down- 
regulated in older β-cells (Figure 6b & 6c). Literature survey and unbiased 
gene ontology analysis using DAVID (Huang et al, 2009) revealed that the 
upregulated genes were involved in the negative regulation of growth-factor 
signaling including socs2, cish, spry4 and fstl1 (Figure 6d). Expectedly, genes 
involved in ER stress including trib3 and cebpd, as well as genes associated 
with increased risk of developing type 2 diabetes and glucose intolerance 
were enriched in older β-cells (prtfa, lpp and socs2) (Fang et al, 2014, Szabat 
et al, 2016, Kato et al, 2006, Lebrun et al, 2010, Nair et al, 2014, Liu et al, 
2008). 
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Figure 6: Transcriptome profiling of younger and older β-cells reveals 
heterogeneous activation of gene expression 
(a) Schematic showing isolation and FAC-sorting of β-cells from Tg(ins:nlsRenilla- 
mKO2) animals at 3 mpf and 1 ypf followed by high-throughput mRNA-Sequencing. 
(b) Heatmap depicting differentially regulated genes among the β-cells at 1 ypf and 3 
mpf involved in β-cell proliferation, function and inflammation (asterisk denotes genes 
e 
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validated by single-cell qPCR). (c) Volcano plot representing the distribution  of 
genes that were differentially regulated in β-cells from 1 ypf and 3 mpf (1.5-log2fold 
change, p<0.05). (d) Unbiased gene-ontology analysis using DAVID of genes 
enriched in β-cells at 1 ypf (p < 0.05). (e) Candidate genes enriched in β-cells at 1  
ypf were validated using single-cell qPCR. Violin plots denote expression distribution 
of the candidate genes. The Y-axis shows -log10(Ct) values of transcript levels in 
single β-cells. The X-axis shows genes names and the respective developmental 
stages. The percentage values under each violin plot denote the proportion of β-  
cells with detectable transcript levels. The value -1.6 -log10(Ct) represents no 
detectable expression as measured by single-cell qPCR. Each dot represents one β- 
cell (two-tailed t-test, * p<0.05). 
 
 
 
 
To probe the heterogeneity among β-cells at these stages and to 
validate the changes in gene-expression at the level of individual cells, single- 
cell qPCR of selected candidate genes were performed on sorted β-cells 
(Figure 6e). Genes with significantly up-regulation in β-cells from older 
animals, were selected as “representative” genes from each category (ER- 
stress, negative regulation of growth-factor signaling, and β-cell function). An 
interesting observation revealed that the proportion of cells expressing the 
highly enriched genes increased with age. These data indicated that with 
increasing animal age, individual β-cells turned-on the expression of 
candidate genes in an asynchronous pattern. 
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3.3. Heterogeneous activation of NF-kB signaling in 
the β-cells with age 
Gene expression analysis in greater detail revealed an enrichment of 
members of the NF-kB pathway and genes involved in inflammation, including 
il15, c9, tnfrsf1b, cd74a, cd74b, were enriched in β-cells from older islets. 
Indeed, cytokine mediated signaling was overrepresented in the gene 
ontology analysis performed using DAVID. Single-cell qPCR of the upstream 
gene tnfrsf1b also revealed a heterogeneous upregulation in β-cells with age 
(Figure 6e). The receptor tnfrsf1b belongs to a superfamily of cytokine 
receptors, which respond to Tumor Necrosis Factor (TNF) and activate NF-kB 
pathway, an inducible and ubiquitous transcription factor which senses 
inflammation (Aggarwal et al, 2012)(Espín-Palazón et al, 2014). In order to 
test if overexpressing tnfrsf1b in β-cells could indeed induce NF-kB signaling, 
tnfrsf1b was cloned in under the regulation of insulin promoter and injected it 
into one-cell-stage embryos. The injection of the plasmid at one-cell stage 
leads to random genomic integration events in different cells such that 
ins:tnfrsf1b expression is mosaic but specific to β-cells (Figure 7a). 
An efficient NF-kB signaling reporter line Tg(NF-kB:GFP) was used to 
study the signalling activity of NF-kB transcription factor (Kanther et al, 2011). 
This reporter expresses GFP under the control of six tandem NF-kB binding 
sites, such that GFP is expressed upon the nuclear translocation and binding 
of NF-kB dimer to the NF-kB binding sites. Indeed, a higher proportion of β- 
cells was observed in animals injected with ins:tnfrsf1b expressed GFP at 5 
dpf compared to controls. A total of 32.2 % ± 32.07 β-cells (n=6) in the 
tnfrsf1b-injected animals expressed GFP as compared to 2.4 % ± 1.98 β-cells 
(n=5) in the controls (Figure 7b). 
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Figure 7: tnfrsf1b activates NF-kB reporter in a cell autonomous manner 
 
(a) The images show single confocal planes from islets of 5 dpf larvae. The tnfrsf1b 
coding sequence was expressed under the control of the insulin promoter. The 
plasmid was injected in Tg(NF-kB:GFP) embryos at the one-cell-stage, leading to 
mosaic and stochastic expression of the construct in β-cells. The Tg(NF-kB:GFP) 
reporter expresses GFP (green) under the control of six tandem repeats of NF-kB 
DNA-binding sites. Β-cells were labelled using an insulin  antibody  (magenta). 
Arrows indicate GFP-positive β-cells. Scale bar 10 µm. (b) The graph shows the 
percentage of GFP-positive and insulin-positive cells in uninjected controls (n=5) and 
tnfrsf1b injected animals (n=6) at 5 dpf. Horizontal bars represent mean values. 
 
 
Enrichment of the NF-kB pathway in β-cells from older islets indicated 
an activation of this pathway with age. Temporal image analysis of β-cells 
from Tg(NFkB:GFP) animals was performed in order to investigate this 
pathway at a cellular-level. The GFP expression levels were too low to be 
detected without amplification in islets from 1 mpf. The GFP expression in β- 
cells from 3 mpf islets was detectable and exhibited a salt-and-pepper pattern, 
suggesting heterogeneous NF-kB activation, which was consistent with the 
heterogeneous expression of tnfrsf1b as revealed by single-cell qPCR. 
Notably, nearly all β-cells in islets from 1 ypf animals express GFP at different 
levels (Figure 8a). In order to quantify the proportions of GFP-high β-cells in 
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Figure 8: An inflammation reporter reveals heterogeneous activation of NF-kB 
signaling in β-cells with age 
(a) Top- Confocal projections of islets from Tg(NF-kB:GFP) animals at 1 mpf, 3 mpf 
and 1ypf. β-cells were labelled using an insulin antibody (magenta). NF-kB:GFP 
reporter expression is shown in green. Scale bars 20 µm. Bottom- Insets show high 
magnification single planes of the confocal stacks (corresponding to the regions 
31 
NF-kB signaling as a marker of age-associated 
heterogeneity among β-cells 
 
 
 
shown using white dotted-lines in the top panels). Scale bar 10 µm. (b-c) Β-cells  
from 3 mpf Tg(NF-kB:GFP) animals were labelled with TSQ (Zn2+ labelling dye) and 
analyzed using FACS. (d) The graph shows GFP intensity (along the X-axis) and the 
distribution of β-cells at 3 mpf and 1 ypf. Horizontal lines indicate the division point 
between GFPlow and GFPhigh levels. Percentage values represent proportion of cells 
with GFPlow or GFPhigh expression. 
 
 
younger and older islets, β-cells were labelled with the Zn2+ chelator TSQ 
(Kim et al., 2000), which preferentially labels β-cells due to their high zinc 
content. Zn2+ labelled cells were then passed through FACS and were 
analyzed for the levels of GFP expression in each cell (Figure 8b & 8c). Flow 
cytometry analysis of β-cells from 3 mpf and 1 ypf animals confirmed the 
presence of two β-cell populations at each stage based on GFP-fluorescence 
intensity (n=10) (Figure 8d). A higher proportion of β-cells express GFP in 1 
ypf islets. The above experiments showed that not only does the overall GFP 
expression in individual β-cells increases with age, but the proportion of β- 
cells with GFP expression increase with age. 
A similar pattern of GFP expression was observed in the secondary 
islets (Figure 9a). The GFP expression levels were too low to be detected in 
the secondary islets from 1 mpf. The GFP expression in β-cells from 3 mpf 
islets was detectable and exhibited a salt-and-pepper pattern, and nearly all 
β-cells in secondary islets from 1 ypf animals express GFP at different levels. 
Finally, to ensure if the GFP mRNA levels correlated with the GFP protein 
levels, we first sorted single β-cells/well into a 96-well plate using index sort 
function of ARIA-II. Single-cell qPCR was then performed on the β-cells 
against GFP and Cp values were obtained for each cell. Indeed, a positive 
correlation (R2 = 0.25) between the mRNA expression levels and the GFP 
intensity measured using FACS was observed (Figure 9b). 
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Figure 9: Heterogeneous activation of NF-kB signaling in β-cells of secondary 
with age 
(a) Top- Confocal projections of secondary islets from Tg(NF-kB:GFP) animals at 1 
mpf, 3 mpf and 1ypf. β-cells were labelled using an insulin antibody (magenta). NF- 
kB:GFP reporter expression is shown in green. Scale bar,s 20 µm. Bottom- Insets 
show high magnification single planes of the confocal stacks (corresponding to the 
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regions shown using white dotted-lines in the top panels). Scale bar 10 µm. (b) Β- 
cells from 3 mpf Tg(NF-kB:GFP);Tg(ins:dsRed) animals were FAC-sorted using  
index sort. mRNA levels of GFP were measured in single FAC-sorted β-cells. The 
graph shows log10(GFP intensity) (along the Y-axis) and Cp values of GFP mRNA 
(along X-axis). Line indicates the correlation between GFP fluorescence intensity and 
GFP-mRNA expression levels in single cells. Each dot represents one β-cell. 
 
 
 
 
3.4. β-cells with higher NF-kB reporter activity 
proliferate less compared to their neighbors 
The observation that proliferation in β-cells declines with age and the 
levels of NF-kB in the islet increase with age pointed to an inverse correlation 
between Nf-kB and proliferation. In order to identify the role of NF-kB on β-cell 
proliferation, 5-ethynyl-2´- deoxyuridine (EdU) incorporation assay was used 
to mark the proliferating β-cells in 3 mpf Tg(NFkB:GFP) animals. Animals 
were treated with EdU for 2 consecutive overnights while maintain them in 
system water during the day. A time-period of 2 days was chosen to ensure 
enough number of proliferating cells to be captured by the assay. Cells were 
examined for the levels of NF-kB:GFP by calculating the normalized GFP 
intensity in all β-cells in the islets of 3 mpf animals (n=9) (Figure 10a). 
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(a) EdU incorporation assay was performed to mark the proliferating β-cells in Tg(NF-
kB:GFP) animals at 3 mpf. The confocal image (single plane) shows an overview of a 
section through the islet. β-cells were labelled with an insulin antibody (magenta), a 
GFP antibody (green) and EdU (blue). Arrows point to EdU-positive β- cells. Right- 
The insets show higher magnification single planes images with  separate channels. 
EdU incorporation can be observed in some of the GFPlow cells (white arrow-heads). 
(c) A region-of-interest (ROI) was drawn over the  widest section of the nucleus of the 
insulin-positive cells and normalized GFP-intensity 
Figure 10: NF-kB:GFPhigh β-cells proliferate less than their neighbors 
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(mean GFP-intensity/mean DAPI-intensity) was measured for each ROI. The  
average total normalized GFP-intensity of each islet was set as a threshold for 
dividing the cells into GFPhigh and GFPlow populations. The graph shows the 
percentage of EdU and insulin double-positive cells among the GFPhigh and GFPlow 
populations. Each dot represents one islet (n=9). Horizontal bars represent mean 
values (two-tailed t-test, * p<0.05). (d) EdU incorporation assay was performed to 
mark the proliferating β-cells in Tg(NF-kB:GFP) animals at 3 mpf. A region-of- 
interest (ROI) was drawn over the widest section of the nucleus of insulin-positive 
cells and normalized GFP-intensity (mean GFP-intensity/mean DAPI-intensity) was 
measured for each ROI. The graph shows normalized GFP-intensity among EdU- 
positive and EdU-negative β-cells. Each dot represents one cell. 
 
 
 
 
 
The total normalized mean GFP intensity of all the sections belonging to one 
islet, designated GFPtotal, was set as a threshold for each respective islet. 
The β-cells with normalized mean GFP intensity higher than GFPtotal 
werecategorized as NF-kB:GFPhigh while cells with normalized mean GFP 
intensity lower than GFPtotal were categorized as GFPlow. A lower proportion of 
the NF-kB:GFPhigh cells had incorporated EdU over a two-day period as 
compared to GFPlow cells, suggesting that NF-kB could play a role in inhibiting 
β-cell proliferation (Figure 10b & 10c). In order to confirm if the GFP intensity 
remains stable during the time of EdU incorporation, β-cells were sorted into a 
384-well plate, such that one well contained one cell. The GFP intensity of 
cells was followed over 72 hours. Indeed, the GFP intensity remained stable 
for 72 hours and did not change significantly (Figure 11a & 11b). 
36 
NF-kB signaling as a marker of age-associated 
heterogeneity among β-cells 
 
 
 
 
 
 
Figure 11: NF-kB:GFP expression is stable in NF-kB:GFPhigh and NF- 
kB:GFPlow cells 
(a) β-cells from Tg(NF-kB:GFP) animals at 3 mpf were FAC-sorted as single 
cells in 384-well plates and followed over 72 hours. Top- NF-kB:GFPhigh cells 
at 24, 48 and 72 hours post FAC-sorting. Bottom- NF-kB:GFPlow cells at 24, 
48 and 72 hours post FAC-sorting. The GFP intensity remains stable over at 
least 72 hours. (b) Quantification showing the mean GFP fluorescence 
intensity of GFPhigh and GFPlow cells (n=7 GFPhigh cells and n=5 GFPlow cells). 
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3.5. socs2 is enriched in NF-kB:GFPhigh β-cells and 
inhibits proliferation 
To investigate molecular factors underlying lower proliferation of NF- 
kB:GFPhigh β-cells, FACS was used to separate β-cells from 3 mpf animals 
into GFPhigh and GFPlow populations using a double transgenic line 
Tg(ins:mKO2); Tg(NF-kB:GFP) (Figure 12a). Expression levels of selected 
candidate genes that previously identified to be significantly enriched in β- 
cells from older animals (1 ypf) was quantified using RT-qPCR analysis of the 
GFPhigh and GFPlow populations. The gene socs2 showed more than 2.5 fold 
higher expression (n=4, 1000 cells each) (Figure 12b) in the GFPhigh cells 
compared to GFPlow, whereas other genes did not exhibit higher expression. 
To check if higher levels of socs2 expression can inhibit β-cell proliferation, a 
bi-cistronic construct containing CFP linked to socs2 via a viral T2A sequence 
was cloned under the control of the insulin promoter. Injecting the plasmid in 
one-cell-stage zebrafish embryos leads to mosaic and stochastic expression 
of socs2 in β-cells at later stages (Figure 12c). To quantify the effect of socs2 
expression on proliferation, the plasmid was injected in Tg(ins:Fucci- 
G1);Tg(ins:Fucci-S/G2/M) embryos, such that β-cells in the G0/G1 phases of 
cell-cycle were labelled in red, whereas cells in the S/G2/M phases of cell 
cycle were labeled in green. The CFP-tag marked the β-cells expressing 
socs2 in the islets at 23-25 dpf, a stage of development characterized by 
higher rates of β-cell proliferation. 
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Figure 12: socs2 is enriched in NF-kB:GFPhigh cells and inhibits β-cell 
proliferation in a cell-autonomous manner 
(a) Contour plot showing FACS of live RFP-positive GFPhigh and GFPlow cells from 
Tg(NF-kB:GFP);Tg(ins:dsRed) animals at 3 mpf. Live cells were labelled with 
calcein.(b) Bulk RT-qPCR was performed on the GFPhigh and GFPlow β-cells (1000 
cells from four replicates). The graph shows relative fold-change between the control 
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gene β-actin and socs2 in GFPhigh and GFPlow cells.  socs2 shows higher expression 
in the GFPhigh cells. (two-tailed paired t-test, *p<0.05) Error bars, SD. (c) Schematic 
showing the method for mosaic overexpression of candidate genes in β-cells. The 
socs2 coding sequence is linked to nuclear-CFP using a T2A sequence. The entire 
construct was expressed under the insulin promoter. This construct was injected in 
one-cell-stage-embryos from Tg(ins:Fucci-G1);Tg(ins:Fucci-S/G2/M) animals leading 
to mosaic and stochastic expression of socs2 in β-cells during islet development. 
Control animals were injected with plasmid containing only nuclear-CFP sequence. 
(d) Confocal projections showing mosaic expression of socs2-T2A-CFP (blue) at 23 
dpf (blue). Proliferating β-cells are marked by Tg(ins:Fucci-S/G2/M) expression 
(green) and absence of Tg(ins:Fucci-G1) expression (magenta). Anterior to the left. 
Scale bar 20 µm. Right- Insets show higher magnification single planes from the 
confocal stacks (white dotted-line) with separate channels. (e) Quantification of the 
percentage of Tg(ins:FUCCI-S/G2/M)-positive and Tg(ins:FUCCI-G1)-negative 
(green only) β-cells. The socs2 expressing β-cells exhibit reduced cell-cycle 
progression compared to wild-type neighbours (n=9). Horizontal bars  represent 
mean values (two-tailed t-test, * p<0.05). (f-h) Quantification of the percentage of 
Tg(ins:FUCCI-S/G2/M)-positive and Tg(ins:FUCCI-G1)-negative (green only) β-cells 
among the CFP-positive and CFP-negative sub-populations for each experiment. 
Horizontal bars represent mean values (two-tailed t-test, p > 0.05). 
 
 
Quantification revealed 8.44% ± 3.37 of the CFP-negative β-cells to be 
proliferating,while only 1.08% ± 1.65 CFP-positive β-cells exhibited cell-cycle 
progression (n=9) (Figure 12d & 12e). Overexpression of CFP alone, or CFP- 
T2A-rapgef4 and CFP-T2A-spry4 in this mosaic manner did not affect 
proliferation (Figure 12f-h). Thus, socs2 can inhibit β-cell proliferation in a cell- 
autonomous manner. Altogether, these results suggest that the higher 
endogenous expression of socs2 in NF-kB:GFPhigh compared to NF- 
kB:GFPlow β-cells could contribute to the proliferative heterogeneity among β- 
cells. 
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3.6. Immune cells infiltration as a potential source of 
cytokines in zebrafish islet 
An enrichment of genes associated with an inflammatory signature 
together with the heterogeneous activation of the NF-kB pathway in the β- 
cells might suggest an active cross-talk between the β-cells and the islet 
microenvironment. One of the important mediators of inflammatory response 
and regulation are the tissue-resident macrophages (Morris, 2015). To study 
this cell type in the developing islet, immune cells were labelled using a pan- 
leukocyte marker, L-plastin, which marks the monocyte/macrophage lineage 
in zebrafish (Mathias et al, 2010). Although innate immune cells were largely 
absent within the islets during the larval stages (15-21 dpf) of development, 
they had started infiltrating the islets during the late juvenile stages (45 dpf) 
(Figure 13a). A macrophage reporter line, Tg(mpeg1:mCherry) was utilized to 
identify the innate immune cells as macrophages. The presence of immune 
cells infiltrating the developing islets made them a potential source of 
cytokines such as TNFα in the islet microenvironment. 
To test this hypothesis, a TgBAC(tnfα:GFP) transgenic line was used to 
examine the presence of TNFα-expressing L-plastin-positive population in the 
islet (Marjoram et al, 2015). On average 25% ± 10.9 (n=5) and 17% ± 11.1 
(n=5) of the L-plastin positive cells inside the islet expressed tnfα:GFP in 3 
mpf and 1 ypf animals, respectively (p >0.05) (Figure 13b & 13c). However, 
the number of tnfα:GFP-positive cells, as well as the total number of L-plastin- 
positive cells showed increasing trends in older islets (Figure 13d & 13e). 
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Figure 13: Immune cells infiltrate the islet during early stages of development 
and persist throughout adult life 
(a) Confocal images of pancreata from 15, 21 and 45 dpf animals. Β-cells were 
labelled using an insulin antibody (grey), leukocytes were labelled using an L-plastin 
antibody (magenta) and Tg(ptf1a:GFP) marks the acinar cells (green). Immune cells 
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are present within the islet at 45 dpf (arrows). (b) Left- Confocal projection image of 
whole islets from Tg(tnfα:GFP) animals at 1 ypf. Islets were labelled using TSQ 
(Zn2+ labelling dye) (blue), leukocytes were labelled with an L-plastin antibody 
(magenta) and TgBAC(tnfα:GFP) marks cells expressing tnfα (green). Scale bars 20 
µm. Right- Insets show high magnification single plane from the confocal stacks 
(corresponding to the area marked using a white dotted-line). Scale bar 10 µm. (c) 
Quantification of the percentage of TgBAC(tnfa:GFP) and L-plastin double-positive 
cells over the total number of L-plastin-positive cells in the islets of Tg(tnfa:GFP) 
animals at 3 mpf (n=5) and 1 ypf (n=5). Horizontal bars represent mean values (two- 
tailed t-test, p > 0.05). (d-e) Quantification of the total number of Tg(tnfa:GFP)- 
positive and L-plastin double-positive cells at 3 mpf (n=5) and 1 ypf (n=5). Horizontal 
bars represent mean values (two-tailed t-test, p > 0.05). 
 
 
 
We next wanted to test whether TNFα was capable of activating NF-kB 
signaling in the β-cells. A plasmid expressing tnfα gene under the control of 
insulin promoter was injected in one-cell-stage Tg(NF-kB:GFP) embryos and 
GFP expression was analyzed in β-cells at 5 dpf. Indeed, TNFα alone could 
induce NF-kB:GFP reporter expression in the β-cells (Figure 14a & 14b). 
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Figure 14: tnfa can induce NF-kB:GFP reporter expression in a cell 
autonomous manner 
(a) Confocal projection images showing islets at 5 dpf. The tnfα cDNA was  
expressed under the insulin promoter. The plasmid was injected in Tg(NF-kB:GFP) 
embryos at the one-cell-stage and the islets were analyzed at 5 dpf. Β-cells were 
labelled with an insulin antibody (red). Tg(NF-kB:GFP) reporter expression is shown 
in green. (b) The graph shows the percentage of GFP and insulin double-positive 
cells in un-injected controls (n=7) and ins:tnfα injected animals (n=8) at 5 dpf. 
Horizontal bars represent mean values (two-tailed t-test, * p<0.05). 
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4 
Discussion 
4.1. Heterogeneity and aging 
 
The two important observations in this thesis, that is (a) β-cells of a 
developing islet display proliferative and functional heterogeneity based on 
time of differentiation and (b) the observation that an adult islet consists of a 
mixed population β-cells displaying varied levels of NF-kB:GFP add to the 
current literature of growing evidence of molecular and functional 
heterogeneity among the β-cells (Bader et al, 2016, Dorrell et al, 2016, Li et 
al, 2015, Segerstolpe et al, 2016, Wang et al, 2016, Xin et al, 2016, Singh et 
al, 2017). The first observation is in line with recent work, which showed 
evidence of position-based heterogeneity, suggesting that newly differentiated 
“virgin β-cells” are preferentially added to the periphery of the islet which 
serves as a life-long niche for neogenesis in mice (Meulen et al, 2017). The 
second observation points to a molecular marker that is expressed in a sub- 
population of β-cells and is dynamic with age. In addition, the  single-cell 
qPCR data demonstrate that genes involved in inflammation and β-cell 
function such as tnfrsf1b, cish and rapgef4 are enriched in a sub-population of 
β-cells in an adult animal, and the proportion cells in the sub-populations 
increase with age. Furthermore, another group identified IGF1R as a new 
marker of aging in β-cells , and showed evidence of intra- and inter-islet 
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heterogeneity among the β-cells (Aguayo-mazzucato et al, 2017). Altogether, 
both observations along with the recent literature indicate that β-cells of 
varying relative ages co-exist within the same islet. Various factors may 
underlie the heterogeneity in relative-age among β-cells including their time of 
differentiation, differences in their responsiveness to glucose or differences in 
their cross-talk with environmental factors. 
 
 
4.2. Inverse correlation between proliferation and 
function 
Our study shows that, during development the newly formed β-cells are 
more proliferative and less functional. However, these differences subside 
when the β-cells become mature with age. Further experiments are required 
to show that indeed a proliferating cell is less functional as compared to a 
more quiescent β-cell. Using optogenetic tools, intra-cellular Ca2+ levels in the 
β-cells can be increased, thus mimicking cellular function. This can be used 
as a proxy to study the effect of increased functional load on β-cell 
proliferation. On similar lines, expression of flat-top gene was shown to 
identify a sub-population of β-cells that were more functional as compared to 
flat-top negative β-cells in mice (Bader et al, 2016). In another study, four sub- 
populations were shown to exist in human islets that differed in their glucose 
responsiveness (Dorrell et al, 2016). This provides evidence in addition to our 
study that indeed the β-cells divide the workload of function and proliferation 
to dedicated subsets. Notably, it was shown that forced expression of p16, 
which arrests the cell in senescence, made the β-cells more functional 
(Helman et al, 2016). Conversely, it was also shown that making the β-cells 
produce less insulin made them more proliferative (Szabat et al, 2016). 
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4.3. Regulators of β-cell proliferation with age 
 
By combining bulk and single-cell transcriptomics, we show that NF-kB 
signaling is increased in β-cells from older animals and identified NF-kB 
signaling as a potential regulator of proliferation in older β-cells via socs2. 
Inducing proliferation in older cells is difficult, and previous studies have 
identified some signaling pathways and genes induce proliferation of older, 
largely quiescent β-cells. One study shows age-dependent decline of 
transcripts    encoding    the     platelet     derived     growth     factor-  
receptors Pdgfra and Pdgfrb as well as its ligand PDGF using transcriptome 
analysis of wild-type mice ranging from 2 weeks to 13 months of age. This 
pathway was shown to be responsible for the decline in β-cell proliferation 
with age, and proliferation in older β-cells could be induced by over- 
expressing the components of this pathway (Chen et al, 2011). In another 
example, the transcription factor FoxM1 was shown to be a negative-regulator 
of β-cell proliferation in old β-cells and expression of its activated form in aged 
β-cells was shown to successfully induce proliferation (Golson et al, 2015). 
Further genetic gain-of-function experiments would be required to conclude 
the role of NF-kB signaling in β-cell proliferation. For example, over- 
expression of constitutive–active IkK or ectopic expression of tnfrsf1b in the β- 
cells will allow us to study the effect of chronic inflammation on β-cell 
proliferation and function. 
 
 
4.4. Inflammation and β-cells 
 
This study opens the important question as to whether the activation of 
NF-kB signaling plays an active role to lock the β-cells in a quiescent state in 
older animals. It was shown that compared to NF-kB:GFPlow cells, NF- 
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kB:GFPhigh cells proliferate less and express higher levels of socs2, which 
inhibits β-cell proliferation. In another study by Lindberg et al., it was shown 
that induction of a related gene socs3 in rat islets inhibits Gonadotrophin 
Hormone-mediated β-cell proliferation (Lindberg et al, 2005). Indeed, NF-kB 
signaling has been shown to play a role in restricting β-cell proliferation by a 
recent study, which showed that Osteoprotegerin (Opg), a soluble decoy 
receptor member of the Tumor Necrosis Factor (TNF) Receptor Superfamily 
(TNFRSF) stimulates proliferation in mouse and human β-cells. Furthermore, 
a RANKL-specific antibody Denosumab, as well as a genetic deletion of 
RANK in islets stimulated β-cell proliferation, indicating that RANK/RANKL 
acts as a brake on β-cell proliferation (Kondegowda et al, 2015). Furthermore, 
the global and β-cell specific inhibition of NF-kB signaling is known to protect 
β-cells from multiple low-dose Streptozotocin induced diabetes (Mabley et al, 
2002, Eldor et al, 2006). In contrast, a more recent study, which genetically 
manipulated NF-kB activity in β-cells by expressing a non-degradable IκBα or 
a constitutively active IKKβ under the rat insulin promoter, did not report 
altered glucose tolerance in these mice (King et al, 2013). Therefore, further 
studies will be necessary to dissect the role of NF-kB in β-cell proliferation at 
different levels of its activity. Indeed, designing a dominant-negative form of 
IkB in the β-cells may help to strengthen the link between NF-kB signaling and 
β-cell proliferation. 
It is important to note that in addition to NF-kB signaling, other 
inflammatory mediators could play an instructive role in β-cell proliferation. For 
instance, the prostaglandin receptors (E Prostanoid Receptor 3 and 4) might 
also regulate β-cell proliferation in an age-dependent manner such that 
blocking EP3 enhanced Placental-Lactogen (PL) mediated β-cell proliferation 
significantly in younger mice but not in older mice (Carboneau et al, 2017). 
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4.5. Immune cell-islet cross talk and other sources of 
cytokines in the islet microenvironment 
Our study showed that immune cells start infiltrating the islet during late 
juvenile stages of development. This time-point coincides with the activation  
of NF-kB signaling and reduced proliferation in the islet. In addition, during 
adult stages, a fraction of the infiltrating macrophages express TNFα, a 
marker of activated macrophages (Mosser & Edwards, 2008). The presence 
of activated macrophages in the islet microenvironment during development 
may act as a potential source of cytokines. A recent report shows a similar 
observation, wherein the islet-resident macrophages in mice are activated and 
express markers such as TNFα, IL1b and MHC-II proteins (Ferris et al, 2017). 
Since the number of activated immune cells did not increase with age, one 
can argue against a role for tnfα-positive immune cells in promoting NF-kB 
activation in β-cells. In this regard, it is important to note that other cell types 
may act as a source of cytokines. Notably, acinar cells were recently shown to 
release TNFα, which in turn induces apoptosis in aged β-cells, pointing 
towards paracrine control of age-related β-cell dysfunction (Xiong et al, 2017). 
However, further studies and new tools will be necessary to identify a direct 
crosstalk between the islet-resident immune cells and β-cell inflammation. To 
study the cross-talk between immune cells and β-cells, over-expression of 
TNFα in the immune cells would help generate a model of chronic inflamed 
environment. However, such a model would also affect the general 
development of the animal. Such a model would require caution and may 
prove difficult to uncouple the indirect effects of systemic inflammation on β- 
cell physiology. 
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4.6. Future directions 
 
Aim 1: Developing tools to study relationship between β-cell function and β- 
cell proliferation 
Rationale: This study points towards an inverse correlation between β-cell 
function and β-cell proliferation in a developing islet. In order to further 
delineate the molecular regulators of the switch between β-cell proliferation 
and function, inducible tools need to be developed. Optogenetic regulators 
such as channelrhodopsin-2 (ChR2) and halorhodopsin have been used 
recently in both neurons and β-cells to control calcium infux in the cells 
(Boyden et al, 2005, Johnston et al, 2016). ChR2 will be expressed under the 
control of the insulin promoter and injected in one-cell staged embryos. As 
previously described, this injection would give rise to mosaic expression of the 
ChR2 in the β-cells. The activation of this channel by exposure to blue light 
would regulate influx of calcium into the β-cells and subsequent release of 
insulin, thus mimicking β-cell function. Once activated for prolonged time 
periods, the islets will be isolated and processed by performing transcriptomic 
profiling of the β-cells containing ChR2 and the wild-type neighbors. This 
would help uncover the molecular players that regulate the balance between 
β-cell function and proliferation 
Aim 2: Investigate islet-resident macrophages as the source of cytokines in 
the islet. 
Rationale: As previously hypothesized, decline in proliferation during the 
juvenile stage of zebrafish coincides with the infiltration of immune cells in the 
islet. To investigate of indeed the activated macrophages activate NF-kB 
signaling is the islet, a transgenic line will be made that expresses NTR under 
the control of mpeg promoter to form Tg(mpeg: YFP-NTR3). Treating these 
animals with Metronidazole with result in ablation of immune cells, following 
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which, NF-kB levels will be examined in the β-cells. If indeed immune cells are 
the source of exogenous tnfα which subsequently increases NF-kB activity in 
the islet, then ablation of immune cells should lead to a noticeable reduction in 
NF-kB reporter activity in the islet. Conversely, TNFα will be expressed under 
the control of mpeg promoter and NF-kB activity will be monitored in the islet. 
However, in order to avoid the effect of chronic over-expression of TNFα, a 
mpeg:CRE-ER inducible transgenic line will be generated to study short-term 
effects of inflammation on the β-cell proliferation and function. 
Aim 3: Study the role of NF-kB in human β-cells. 
 
In future, it would be important to investigate the role of NF-kB in human β-cell 
proliferation and function. To confirm if the molecular regulators of NF-kB 
pathway are also exhibit heterogeneous expression in the human β-cells, 
immunohistochemistry against components of NF-kB pathway will be 
performed on islets from human donors. Furthermore, to study the effect of 
NF-kB inhibition of human β-cell proliferation, islets will be treated with the 
Wedelolactone to study its role in protection and proliferation of β-cells. 
51 
 
 
 
 
 
 
 
 
 
 
 
5 
Methods and Materials 
5.1. Zebrafish strains and husbandry 
 
Wild-type or transgenic zebrafish of the outbred TL, AB, WIK strains were 
used in all experiments. Zebrafish were raised under standard conditions at 
28°C. Animals were chosen at random for all experiments. The sex and 
genetic background of the animals were not taken into consideration during 
group allocation. Published transgenic strains used in this study were 
Tg(ins:FUCCI-G1)s948 (Ninov et al, 2013), Tg(ins:FUCCI-S/G2/M)s946 
(Ninov et al, 2013), Tg(NF-kB:GFP)(Kanther et al, 2011), 
TgBAC(tnfa:GFP)(Marjoram et al, 2015), Tg(ins:nlsRenilla-mKO2) (Singh et 
al, 2017), Tg(ins:BB1.0L) (Singh et al, 2017), Tg(ins:mCherry-stop-GFP) 
(Hesselson et al, 2011), Tg(mpeg1:mCherry)(Ellett et al, 2011). Experiments 
were conducted in accordance with the Animal Welfare Act and with 
permission of the Landesdirektion Sachsen, Germany (AZ 24–9168, 
TV38/2015, A12/2016, A5/2017). 
 
 
5.2. Cloning and constructs 
 
To generate ins:Flag-tnfrsf1b;cryaa:RFP, a vector was created by inserting 
multiple cloning sites (MCS2) downstream of the insulin promoter to yield 
ins:MCS2;cryaa:RFP. To do so, the plasmid ins:mAG-zGeminin;cryaa:RFP 
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was digested with EcoRI/PacI and ligated with dsDNA generated by annealing 
two primers harboring the sites SpeI, BamHI, EcoRV and lanked by 
EcoRI/PacI overhangs. The plasmid pUC consisting of the tnfrsf1b flanked by 
EcoRI/PacI sites was synthesized from GenScript. Primers were designed 
such that EcoRI site was destroyed in the process of inserting tnfrsf1b under 
the insulin promoter. ins:MCS2;cryaa:RFP and the plasmid pUC-Flag-tnfrsf1b 
were subsequently digested with EcoRI/PacI to yield compatible fragments, 
which were ligated together to yield the final construct. The entire construct 
was flanked with I-SceI sites to facilitate transgenesis. To generate ins:CFP- 
T2A-socs2;cryaa:RFP, a vector was created by inserting multiple cloning sites 
(MCS2) downstream of the insulin promoter to yield ins:MCS2; cryaa:RFP. To 
do so, the plasmid ins:mAG-zGeminin;cryaa:RFP was digested with 
EcoRI/PacI and ligated with dsDNA generated by annealing two primers 
harboring the sites SpeI, BamHI, EcoRV and flanked by EcoRI/PacI 
overhangs. The plasmid pUC consisting of the candidate gene socs2 fused to 
CFP via T2A sequence flanked by EcoRI/PacI sites was synthesized from 
GenScript. Primers were designed such that the EcoRI site was destroyed in 
the process. ins:MCS2;cryaa:RFP and the plasmid  pUC-CFP-T2A-socs2 
were subsequently digested with EcoRI/PacI to yield compatible fragments, 
which were ligated together to yield the final construct. The entire construct 
was flanked with I-SceI sites to facilitate transgenesis. Same process as 
described above was used for generating ins:CFP-T2A-spry4;cryaa:RFP 
construct. 
To generate ins:CFP-T2A-rapgef4;cryaa:RFP, a plasmid pUC consisting of 
rapgef4 flanked by SpeI/PacI sites was synthesized from GenScript. ins:CFP- 
T2A-socs2;cryaa:RFP and the plasmid pUC-rapgef4 were subsequently 
digested with SpeI/PacI to yield compatible fragments, which were ligated 
together to yield the final construct. 
53 
Materials and Methods 
 
 
 
5.3. Analysis of proliferation using mosaic integration 
in the genome 
For counting β-cells in Tg(ins:FUCCI-G1);Tg(ins:FUCCI-S/G2/M) with mosaic 
expression of candidate genes, the “spots” function of Imaris (Bitplane) was 
used after thresholding. The total number of CFP-positive red cells and CFP- 
negative red cells in the entire islet spanning all stacks were calculated. All  
the Tg(ins:FUCCI-S/G2/M)-positive cells were counted manually for CFP- 
positive and CFP-negative β-cells. 
 
Percentage of CFP − positive proliferating cells = 
 
CFP − positive and ins: Fucci − S/G2/M − positive and ins: FUCCI − G1 − negative cells 
Total CFPpositive cells 
 
 
Percentage of CFP − negative proliferating cells = 
CFP − negative and ins: Fucci − S/G2/M − positive and ins: FUCCI − G1 − negative cells 
Total CFPnegative cells 
 
 
 
5.4. Tissue collection and sectioning 
 
To facilitate confocal imaging of the islet, the pancreas was dissected from the 
gut (juvenile and adults) after fixation. Fish were euthanized in Tricaine prior 
to dissection of gut, and the samples immersed in 4% paraformaldehyde for 
48 hours at 4°C. The pancreas was then manually dissected and washed 
multiple times in PBS. For cryo-sectioning, the tissue was then immersed in 
20% sucrose solution overnight at 4°C. The tissue was then embedded in 
20% sucrose + 7.5% gelatin solution in cryo-molds on dry ice and sectioned at 
14 μm in thickness with Leica cryostat. 
 
 
5.5. Cell counting 
 
Total number of β-cells in the islets were counted using Imaris (Bitplane). For 
counting β-cells in Tg(ins:FUCCI-G1);Tg(ins:FUCCI-S/G2/M), the “spots” 
function of Imaris, with appropriate thresholding, was used to count all the red 
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cells in stacks spanning the entire islet. All the proliferating cells (green only) 
were counted manually. This approach enabled us to quantify the percentage 
of proliferating β-cells in the whole islet. 
 
 
 
 
Percentage of proliferating cells = 
ins: Fucci − S/G2/M − positive and ins: FUCCI − G1 − negative cells 
Total β − cells 
 
 
 
5.6. EdU labeling 
 
To label proliferating cells, 3 mpf fish were placed in 2 mM EdU on two 
consecutive nights, and then placed back in system water with normal feeding 
during each day. The fish were then euthanized, the gut was fixed and the 
pancreas was sectioned as described above. The tissue sections were 
washed 3 X 10 min with PBS, and EdU detection was performed according to 
the kit protocol Click- iT® EdU Alexa Fluor® 647 Imaging Kit (C10340 Fisher 
Scientific). GFP and insulin staining was performed at the concentrations 
described below. 
 
 
5.7. Immunofluorescence and image acquisition 
 
Immunofluorescence was performed on pancreas sections prepared as 
described above. The sections were permeabilized in 1% PBT (TritonX-100) 
and blocked in 4% PBTB (BSA). Primary and secondary antibody staining 
was performed overnight at 4°C. Primary antibodies used in this study were 
anti-insulin (guinea pig, Dako A0564) at 1:200, anti-EGFP (chicken, abcam 
ab13970) at 1:500, and anti-L-plastin (rabbit, Biozol LS-C210139-250) at 
1:1000. Secondary antibodies used in this study were Alexa Fluor 568 and 
Alexa Fluor 488 anti-guinea pig (1:300), Alexa Fluor 647 anti-rabbit (1:300) 
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and Alexa Fluor 488 anti-chicken (1:300. Samples were mounted in 
Vectashield and imaged using a Zeiss LSM 780. 
 
 
 
5.8. GCaMP6s image acquisition and analysis 
 
To monitor the changes in glucose-stimulated calcium influx during 
development, GCAMP6s measurements were performed on isolated islets 
from Tg(ins:gCaMP6s; cryaa:mCherry);Tg(ins:Renilla-mKO2; cryaa:CFP) 
double-transgenic animals. Freshly dissected islets from euthanized fish were 
washed with HBSS containing Ca2+/Mg2+ (Life technologies, 14175095) 
twice and embedded in fibrinogen-Thrombin gels (3:1 ratio of 10 mg/ml 
Bovine fibrinogen, 50 U/ml Bovine thrombin; Sigma Aldrich). Upon 
polymerization, islets were immersed in HBSS containing 5 mM glucose, 
visually oriented along A/P axis and imaged using live confocal microscopy 
(LSM-780 FLIM inverse) to establish the baseline. 
 
 
5.9. Fluorescent intensity analysis 
 
Normalized GFP fluorescent intensity on pancreatic islet sections was 
measured using Fiji (Schindelin et al., 2012), by measuring mean grey 
intensity value for the GFP and DAPI channels in a ROI (region-of-interest) 
created at the widest section of a nucleus. Normalized GFP intensity 
measurement was calculated as a ratio of mean GFP intensity and mean 
DAPI intensity for each ROI. For EdU intensity measurements, mean grey 
intensity value for the EdU channel was calculated along with the GFP and 
DAPI channels in each ROI created at the widest section of a cell as 
described above. To discriminate between GFPhigh and GFPlow cells, a 
threshold was set for each islet individually. The threshold (GFPtotal) was 
calculated as the average normalized GFP intensity of all the images 
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belonging to one islet. Threshold for determining EdU positive cells was set by 
eye. 
 
 
5.10. FACS and gene profile analysis 
 
For RNA-Seq, qPCR and NF-kB population analysis, β-cell isolated from islets 
were sorted and analyzed using FACS-Aria II (BD Bioscience). For 
dissociation, islets were collected in PBS chilled on ice. After one washing 
with ice cold PBS, islets were dissociated into single cells by incubation in 
TrypLE (ThermoFisher, 12563029) with 0.1% Pluronic F-68 (ThermoFisher, 
24040032) at 37 °C in a benchtop shaker set at 350 rpm for 50 min. Following 
dissociation, TrypLE was inactivated with 10% FBS, and the cells pelleted by 
centrifugation at 500g for 10 min at 4 °C. The supernatant was carefully 
discarded and the pellet re-suspended in 500 uL of HBSS (without Ca, Mg) + 
0.1% Pluronic F-68. To remove debris, the solution was passed over a 30 µm 
cell filter (Miltenyi Biotec, 130-041-407). For RNA-Sequencing, total RNA was 
extracted from FACS sorted β-cells using Quick-RNA MicroPrep kit (R1050 
Zymo Research). Sequencing was performed on llumina HiSeq2500 in 
2x75bp paired-end mode. Reads were splice-aligned to the zebrafish 
genome, GRCz10, using HISAT2. htseq-count was used to assign reads to 
exons thus eventually getting counts per gene. EdgeR package of R 
(Robinson et al, 2009) was used to perform differential analysis between 
samples. Across-samples normalization was performed using the TMM 
normalization method. For single-cell qPCR, cDNA was synthesized with 
Quanta qScript TM cDNA Supermix directly on cells. Total cDNA was pre- 
amplified for 16 cycles (1x 95ºC 8’, 18x (95ºC 45’’, 49ºC* 1.30’, 72ºC 1.5’) 1x 
72ºC 7’) (* with 0.3ºC increment/cycle) with the QIAGEN Multiplex PCR Plus 
Kit (Qiagen) in a final volume of 35 µl in the presence of the 10 primer pairs 
(listed in Table S1) (25nM final for each primer). Pre-amplified DNA (10 µl) 
was treated with 1.2 U Exonuclease I and expression quantified by real time 
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PCR on the BioMark™ HD System (© Fluidigm Corporation, CA, USA) using 
the 96.96 Dynamic Array IFC and the GE 96x96 Fast PCR+ Melt protocol and 
SsoFast EvaGreen Supermix with Low ROX (BIO RAD, CA, USA) with 5 µM 
primers (described above) for each assay. Raw data was analyzed using the 
Fluidigm Real-Time PCR analysis software. Pre-analysis cleanup of the qPCR 
data was performed by removing cells with unamplified values (Cp = 999) for 
the house keeping genes b-actin, ef1α and rpl13α. For significance analysis, 
ROTS package (Suomi et al, 2017) was used with default parameters. For 
bulk RTqPCR gene expression profiling, 1000 GFPhigh and GFPlow cells were 
sorted into 5 µl EB Buffer (Qiagen) containing 0.3% IGEPAL and 0.1% BSA 
and immediately snap frozen. The cells were then thawed and incubated on 
ice for 10’. cDNA was synthesized with Quanta qScript TM cDNA Supermix 
directly on cells in a final volume of 30 µl. 15 µl. of cDNA was pre-amplified for 
12 cycles (1x 95ºC 1’, 95ºC 15’’, 60ºC 1’, 72ºC 1.5’) and 1x 72ºC 10’ with the 
TATAA GrandMaster Mix (TATAA Biocenter, Göteborg, Sweden) in a final 
volume of 35 µl in the presence of primer pairs for the following genes: ins, 
cish, spry4, trib3, rapgef4, ef1a, bact2, rpl13, tnfa, tnfrsf1b, socs2 (25nM final 
for each primer). 1.2 µl pre-amplified cDNA was used for quantification by real 
time PCR on the LightCycler480 (Roche, Switzerland) using SYBR® Premix 
Ex Taq TM (Tli RNaseH Plus) (Takara BIO USA, INC.) and 0.2 nM of each 
primer in a volume of 10 µl using the following cycling program: initial 
denaturation 95ºC 30’’, amplification 45x (95ºC 5’’, 60ºC 30’’) and melting 
curves 1x (95ºC 5’’, 60ºC 1’, ramp to 95ºC (ramping rate 0.11)) followed by 
30’’ cooling at 50ºC. Raw data was analyzed using the LightCycler 480 
analysis software. For NF-kB population analysis, dissociated cells were 
incubated in 30 µM solution of TSQ (N-(6-Methoxy-8-Quinolyl)-p- 
Toluenesulfonamide) (ThermoFisher, M-688) for 20 mins to label β-cells. The 
cells were pelleted by centrifugation at 500g for 10 min at 4 °C. The 
supernatant was carefully discarded and the pellet re-suspended in 500 uL of 
HBSS (without Ca, Mg) + 0.1% Pluronic F-68. To remove debris, the solution 
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was passed over a 30 um cell filter (Miltenyi Biotec, 130-041-407) and 
proportion of GFPhigh and GFPlow cells were analyzed by FACS. 
 
 
5.11. Statistical analysis 
 
No statistical methods were used to predetermine sample size, and a 
minimum of 5 animals were used for analysis. The experiments were not 
blinded. Graphs were plotted using R. Statistical analysis was performed 
using R and Microsoft Excel. Values were compared using unpaired Students 
t-test or ANOVA as indicated for each experiment. P-values of <0.05 were 
considered statistically significant. Data are expressed as means ± s.d.unless 
otherwise specified. 
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